Genflow Biosciences PLC Announces Directorate Change

Core Viewpoint - The announcement contains information classified as inside information under the Market Abuse Regulation, which is part of UK domestic law following the European Union (Withdrawal) Act 2018 [1] Group 1 - The company considers the information within the announcement to be significant and relevant for market participants [1]